Ligand validation:4S21

BLA: BILIVERDINE IX ALPHA

BLA is a Ligand Of Interest in 4S21 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4S21_BLA_A_900	23%	7%	0.297	0.921	2.95	1.97	20	14	5	0	100%	1
4S21_BLA_B_900	14%	6%	0.347	0.903	2.87	2.14	15	14	7	0	100%	1
4R6L_BLA_A_900	5%	6%	0.501	0.902	2.84	2.13	18	13	3	0	100%	1
5B4J_BLA_A_301	98%	17%	0.055	0.981	2	1.61	10	5	0	0	100%	1
5VIQ_BLA_A_401	95%	4%	0.067	0.97	2.99	2.59	16	21	1	0	100%	1
3NB8_BLA_A_249	95%	9%	0.068	0.97	2.56	1.99	11	12	0	0	100%	1
7E2S_BLA_A_301	94%	9%	0.063	0.962	2.91	1.56	18	7	0	0	100%	1
5VIK_BLA_A_401	94%	7%	0.068	0.967	2.82	2.1	14	17	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.